Healx
Updates
News
Latest news posts
6 April 2020
Healx using artificial intelligence to find combination drug treatments for COVID-19
Cambridge, UK – 6 April 2020 – Healx, the AI-powered, patient-inspired biotech specialising in rare diseases, today announces it is using its AI platform to develop drug combinations from approved drugs to contribute towards global efforts to find treatments for COVID-19. This focus on combination therapies, where two or more drugs simultaneously target different aspects … Continued
20 March 2020
Webinar | The Rare Treatment Accelerator: Feedback for Applicants
The first call for applications to the Rare Treatment Accelerator saw an extremely high volume of interest and quality of applications received. Following the review of applications by Healx’s selection panel, an initial three patient groups and their diseases were selected to progress to the next stage of the programme. For those patient groups who … Continued
6 April 2020
Cambridge, UK – 6 April 2020 – Healx, the AI-powered, patient-inspired biotech specialising in rare diseases, today announces it is using its AI platform to develop drug combinations from approved drugs to contribute towards global efforts to find treatments for COVID-19. This focus on combination therapies, where two or more drugs simultaneously target different aspects … Continued
20 March 2020
The first call for applications to the Rare Treatment Accelerator saw an extremely high volume of interest and quality of applications received. Following the review of applications by Healx’s selection panel, an initial three patient groups and their diseases were selected to progress to the next stage of the programme. For those patient groups who … Continued
28 February 2020
Cambridge, UK – 28 February 2020 – Healx, the AI-powered and patient-inspired technology company specialising in finding new treatments for rare diseases, today announced that three patient groups – representing different disease areas – have been selected to progress to the next stage of their Rare Treatment Accelerator programme. These groups will each receive up … Continued
4 February 2020
Cambridge, UK – 4 February 2020 – Healx, the AI-powered and patient-inspired technology company specialising in finding new treatments for rare diseases, today announced the appointment of Dr Anthony Hall, MB BS BSc, as Chief Medical Officer (CMO). Tony will be responsible for progressing the company’s rare disease drug candidates through the clinic, with an … Continued
20 December 2019
The Rare Treatment Accelerator is a global partnering programme that gives patient groups and Healx the opportunity to work together to quickly discover and develop repurposed treatments for rare diseases using AI. We have committed a total of $20 million over the next two years towards finding new treatments – investing up to the value … Continued
9 December 2019
Cambridge, UK – 9 December 2019 – Healx the AI-powered biotechnology company focused on developing breakthrough treatments for rare diseases, today announces it has entered into an agreement with Boehringer Ingelheim to identify indications related to rare neurological diseases. The project will leverage Healx’s comprehensive AI-based drug discovery platform, Healnet, and expertise in rare diseases and … Continued
21 November 2019
Cambridge, UK – 21 November 2019 – Healx, the AI-powered and patient-inspired technology company specialising in treatments for rare diseases, today announces that applications are now being accepted for its Rare Treatment Accelerator (RTA). The programme focuses on finding new treatments for rare diseases by partnering with selected rare disease patient groups to leverage the … Continued
5 November 2019
Michale has been featured in recognition of her contribution to Healx’s business through the negotiation and closing of the company’s first pharma deals, navigating new issues such as data use and IP in drug discovery deals using artificial intelligence (AI). In addition to this, Michale has been instrumental in developing Healx’s business activities through two … Continued
1 November 2019
Poster #1: Deep Bidirectional Transformers for Relation Extraction without Supervision NLP Scientist, Yannis Papanikolaou, will be presenting his work on relationship extraction, using a fine-tuning of Google’s BERT language model. Being able to successfully extract relationships despite scarce data is vital to discovering treatments for rare diseases, for which funds – and therefore research – … Continued
16 October 2019
Cambridge, UK – 16 October, 2019 – Healx, the AI-powered and patient-inspired technology company specialising in treatments for rare diseases, today announces that it has raised $56 million in a Series B financing round, led by one of Europe’s largest VC firms Atomico and joined by Intel Capital, Global Brain and btov Partners. All previous … Continued